2 recruiting, 1 completed, 1 not yet recruiting, 1 terminated. 6 Phase 1, 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Recruiting 2, Completed 1, Not yet recruiting 1, Terminated 1, Withdrawn 1 |
| Phase 2 | 5 | Recruiting 2, Completed 1, Not yet recruiting 1, Withdrawn 1 |
Follow Cystectomy: new trials by email Literature Review of Cystectomy trials Research Report on Cystectomy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE Trial Intensity-Modulated Radiation Therapy, Volume Modulated Arc Therapy, Radiosensitizing Agent - Muscle Invasive Bladder Carcinoma, Stage III Bladder Cancer AJCC v8 | Phase 1 / Phase 2 | Recruiting | University of Washington | 12 | 2026-08-20 | 2026-08-25 |
| Disitamab Vedotin Combined With Ivonescimab in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer Disitamab Vedotin Injection, Ivonescimab（AK112，a PD-1/VEGF bispecific antibody）, Radical Cystectomy with Pelvic Lymph Node Dissection - Bladder Cancer, Muscle-invasive Bladder Cancer | Phase 1 / Phase 2 | Not yet recruiting | Sun Yat-sen University | 30 | 2025-04-30 | 2025-05-04 |
| RC48 Combined With Toripalimab as Neoadjuvant Therapy for Cisplatin Ineligible MIBC Patients DisitamabVedotinForIicction Toripalimab - Bladder Cancer, Muscle-Invasive Bladder Carcinoma | Phase 1 / Phase 2 | Recruiting | Zhujiang Hospital | 55 | 2024-06-19 | 2026-10-08 |
| sEphB4-HSA Before Surgery in Treating Patients With Bladder Cancer, Prostate Cancer, or Kidney Cancer Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis, Radical Cystectomy - Infiltrating Bladder Urothelial Carcinoma, Recurrent Bladder Carcinoma | Phase 1 | Terminated | University of Southern California | 2 | 2016-08-02 | 2021-11-24 |
| Phase Ib/II Study Assessing the Neo-adjuvant Combination Therapy of Vinflunine With Cisplatin Followed by Radical Cystectomy in Patients With Muscle-invasive Bladder Cancer (JaNEO) Vinflunine, Cisplatin, Radical cystectomy - Bladder Cancer | Phase 1 / Phase 2 | Withdrawn | Ligartis GmbH | 2016-07-01 | 2018-02-13 | |
| Sirolimus, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Bladder Cancer Cisplatin, Gemcitabine Hydrochloride, Sirolimus - Recurrent Bladder Carcinoma, Stage II Bladder Cancer | Phase 1 / Phase 2 | Completed | University of Washington | 21 | 2013-10-01 | 2017-10-20 |
Urinary Bladder Neoplasms (6) · Carcinoma, Renal Cell (1) · Prostatic Neoplasms (1)
University of Washington (2) · Ligartis GmbH (1) · Sun Yat-sen University (1) · University of Southern California (1) · Zhujiang Hospital (1)
United States (3) · China (2) · Germany (1)
Abai Xu, doctor (1) · David I Quinn, MD (1) · Robert Montgomery (1) · T. Martin Ma, MD, PhD (1) · Zhuowei Liu, M.D Ph.D (1)
2016 (1), P30CA014089 (1), P30CA015704 (1)